Skip to main content
Edwards Lifesciences Logo

Clinical insights on the IntraClude intra-aortic occlusion device

Hospitalization costs banner
Hospitalization costs banner
Hospitalization costs banner

Explore clinical evidence comparing intra-aortic balloon occlusion and external aortic clamping methods.

Real-world evidence comparing hospitalization cost and clinical outcomes evaluation between the endo-aortic balloon and external aortic clamp in cardiac surgery1

objective-icon
objective-icon
objective-icon

Objective

The objective of this study was to validate the results of the STS Database study and evaluate costs associated with external aortic clamping (EAC) versus endo-aortic balloon occlusion (EABO) using the Premier Healthcare Database.

methods-icon
methods-icon
methods-icon

Methods

A 3:1 propensity score- and exact-matched cohort of 1,663 EABO-eligible cardiac surgery cases (10/2015 to 03/2020) was extracted from the Premier database. The researchers examined cost outcomes and clinical outcomes using multivariable generalized linear models to detect differences between groups.

results-icon
results-icon
results-icon

Results

There was no statistically significant difference in total hospitalization costs between EABO versus EAC patient stays. Length of stay was significantly shorter for the EABO group (median (IQR): 6 (5-8) days vs. 7 (5-10) days, P < 0.0001). Rates of myocardial infarction and postcardiotomy syndrome were significantly lower in patients with EABO versus EAC, with no significant differences in any other clinical outcomes.

conclusion-icon
conclusion-icon
conclusion-icon

Conclusion

This real-world evidence suggests that EABO has similar costs and clinical outcomes as the EAC.

Premier Healthcare datatable
Premier Healthcare datatable
Premier Healthcare datatable

Table 1: Comparison of the Premier database to the STS database analysis

Hospitalization costs and clinical outcomes comparison

Hospitalization costs
Hospitalization costs
Hospitalization costs

Cost and clinical outcomes evaluation between the endoaortic balloon and external aortic clamp in cardiac surgery1

The authors compare outcomes and hospital costs of endo-aortic balloon occlusion (EABO) versus external aortic clamping (EAC) in patients undergoing minimally invasive cardiac surgery in a large administrative database.

Endo-aortic balloon occlusion vs. external aortic clamping2

Endo-aortic balloon occlusion is associated with shorter bypass and length-of-stay times in MIS mitral surgery with similar safety and effectiveness.

In an analysis of the STS Adult Cardiac Surgery Database, endo-aortic balloon occlusion was associated with:

  • significantly shorter CPB and LOS
  • similar clinical outcomes

IntraClude intra-aortic occlusion device

The IntraClude device is an integrated system to occlude, arrest, and vent the heart in addition to monitoring aortic root pressure.

intra-aortic occlusion
intra-aortic occlusion
intra-aortic occlusion
intra-aortic occlusion
intra-aortic occlusion
intra-aortic occlusion

The Edwards Advantage

We are committed to providing your institution, clinicians and staff with the highest levels of customer service and support to ensure seamless product implementation and ongoing use, including:

24/7 Technical support

800.822.9837

For product information and orders

800.424.3278

Contact a sales representative

If you would like further information about our privacy policy, please click here.

Would you like to opt-in to receive future email communications from Edwards Lifesciences?

This includes notification of future symposia, forums, conference activities, product updates, and educational events.

References

  1. Balkhy HH, Grossi EA, Kiaii B, et. al Cost and Clinical Outcomes Evaluation Between the Endoaortic Balloon and External Aortic Clamp in Cardiac Surgery. Innovations (Phila). 2023;15569845231185311. doi: 10.1177/15569845231185311.
  2. Balkhy HH, Grossi EA, Kiaii B, et. al A Retrospective Evaluation of Endo-Aortic Balloon Occlusion Compared to External Clamping in Minimally Invasive Mitral Valve Surgery. Semin Thorac Cardiovasc Surg. 2023:S1043-0679(23)00040-0. doi: 10.1053/j.semtcvs.2022.11.016.

Important safety information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse events.